Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) EPS (Weighted Average and Diluted) (2018 - 2025)

Viemed Healthcare (VMD) has disclosed EPS (Weighted Average and Diluted) for 6 consecutive years, with $0.14 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 40.0% year-over-year to $0.14, compared with a TTM value of $0.37 through Dec 2025, up 32.14%, and an annual FY2025 reading of $0.37, up 32.14% over the prior year.
  • EPS (Weighted Average and Diluted) was $0.14 for Q4 2025 at Viemed Healthcare, up from $0.09 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.14 in Q4 2025 and bottomed at $0.02 in Q2 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.06, with a median of $0.06 recorded in 2025.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 91.67% in 2021, then soared 200.0% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.1 in 2021, then decreased by 30.0% to $0.07 in 2022, then increased by 14.29% to $0.08 in 2023, then grew by 25.0% to $0.1 in 2024, then surged by 40.0% to $0.14 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for VMD at $0.14 in Q4 2025, $0.09 in Q3 2025, and $0.08 in Q2 2025.